In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...

Worldwide, hepatitis B is thought to be the second deadliest infection; about 5% of the global population are infection and ...

Vir Biotechnology may be pushing ahead with its combination therapy in hepatitis D, but it's pausing further development in ...

"We were delighted to discover not only important details about the mechanisms of HBV gene regulation, but also a promising path toward a new therapeutic tool against HBV," says Viviana I. Risca, head ...

The research team determined that in order for a critical protein to get made, the hepatitis B virus’s DNA needs to get organized into these DNA-histone complexes. Preventing this from happening ...

The Business Research Company's Key Market Driver In Hepagam B industry 2025: Rising Hepatitis B Prevalence To Fueling Growth It will grow to $XX million in 2029 at a compound annual growth rate (CAGR ...

Researchers identify a history of GI bleeding and three other factors as elevating variceal bleeding risk in patients ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells ...

A new study that has the potential to change the landscape of hepatitis B transmission in Africa. Researchers conducted an analysis revealing key interventions that could effectively eliminate ...

At least one-third of the world's population has been infected with the hepatitis B virus (HBV), and 400 million people are chronic carriers. In most populations, chronic HBV infection is the ...

The hepatitis B vaccine is one of the very first vaccines your baby will get before she leaves the hospital. This vaccine protects her from a dangerous (but preventable!) liver infection and is given ...

With several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue that new direct-acting antiviral drugs, and new NUCs in particular ...